Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | FOLH1 | Q04609 | 3/20 | 0.31 |
| ▸ | GLP1R | P43220 | 3/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19733465 | 0.87 | HPGD (0.32) | HPGDHTTSMN1; SMN2 | |
| SCHEMBL19733633 | 0.85 | — | — | |
| SCHEMBL19733637 | 0.83 | MGLL (0.31) | — | |
| SCHEMBL4964608 | 0.80 | HPGD (0.45) | HPGDHTTSMN1; SMN2GLP1R | |
| SCHEMBL21767237 | 0.80 | SMN1; SMN2 (0.45) | HPGDHTTSMN1; SMN2GLP1R | |
| SCHEMBL20008742 | 0.80 | SMN1; SMN2 (0.48) | HPGDHTTSMN1; SMN2 | |
| SCHEMBL18885626 | 0.80 | SMN1; SMN2 (0.42) | HPGDHTTSMN1; SMN2 | |
| SCHEMBL19732580 | 0.79 | HPGD (0.43) | HPGDHTTSMN1; SMN2GLP1R | |
| SCHEMBL20365824 | 0.79 | SMN1; SMN2 (0.46) | HPGDHTTSMN1; SMN2 | |
| SCHEMBL15773229 | 0.79 | SMN1; SMN2 (0.42) | HPGDHTTSMN1; SMN2FOLH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170360952-A1 | BIOMOLECULE CONJUGATES | CELGENE CORPORATION | 2017-12-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170360952-A1 | BIOMOLECULE CONJUGATES | DNPEP, NAPA, NCL | HPGD 1387/4885HTT 2474/4885SMN1; SMN2 1905/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.